ArticleClinical and molecular hepatology2024

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply.

Hyeyeon Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.